Results 61 to 70 of about 358 (125)
173 POSTER Arf6-AMAP1 pathway in invasion of lung cancer and malignant mesothelioma cell lines
European Journal of Cancer Supplements, 2008 T. Menju +6 more
openaire +1 more source
RAS signaling and remodeling of the immune microenvironment in pancreatic ductal adenocarcinoma: implications of emerging RAS-targeted therapy. [PDF]
Front Cell Dev BiolMeng D, Zhang C.
europepmc +1 more source
Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis. [PDF]
Int J Mol Sci, 2021 Vathiotis IA +3 more
europepmc +1 more source
Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative TherapyA major problem of current cancer research and therapy is prediction of tumor recurrence after initial treatment, rather than the simple biological characterization of the malignancy and proliferative properties of tumors. Breast conservation therapy (BCT) is a well-approved, standard treatment for patients with early stages of breast cancer, which ...
openaire +1 more source
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling. [PDF]
Cancer Cell Int, 2023 Hu Y +5 more
europepmc +1 more source
Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives. [PDF]
Cancers (Basel)Hashimoto A, Hashimoto S.
europepmc +1 more source
GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote AngiogenesisAngiogenesis and cancer invasiveness greatly contribute to cancer malignancy. Arf6 and its effector, AMAP1, are frequently overexpressed in breast cancer, and constitute a central pathway to induce the invasion and metastasis. In this pathway, Arf6 is activated by EGFR via GEP100. Arf6 is highly expressed also in human umbilical vein endothelial cells (
openaire +1 more source
タンキュウ ガヨウ サイボウ U937 ト ニュウガン サイボウ ニ オケル AMAP1 タンパクシツ ノ ハツゲンリョウ チョウセツ キコウ ノ カイセキ
, 2009 京都大学0048新制・課程博士博士(生命科学)甲第14882号生博第179号新制||生||24(附属図書館)27304UT51-2009-K678京都大学大学院生命科学研究科高次生命科学専攻(主査)教授 眞貝 洋一, 教授 藤田 尚志, 教授 山本 憲二学位規則第4条第1項該当Ph.D.
宮田, 真理子
core
Case Report: Novel ASAP1::BRAF fusion in a young adult with low-grade temporal lobe glioma. [PDF]
Front OncolGerasimou P +21 more
europepmc +1 more source